SCHEMBL28660621

SCHEMBL28660621

COc1ccc(C(O)CSc2nnnn2-c2ccc(C(=O)O)cc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 5/20 0.58
▸ LMNA P02545 5/20 0.56
▸ ALDH1A1 P00352 4/20 0.56
▸ MAPT P10636 3/20 0.56
▸ HPGD P15428 3/20 0.56
▸ MEN1 O00255 3/20 0.56
▸ KMT2A Q03164 3/20 0.56
▸ TSHR P16473 2/20 0.56
▸ KDM4E B2RXH2 2/20 0.56
▸ JAK2 O60674 1/20 0.56
▸ PTP4A3 O75365 1/20 0.56
▸ ALPL P05186 1/20 0.56
▸ POLB P06746 1/20 0.56
▸ GAA P10253 1/20 0.56
▸ ALPG P10696 1/20 0.56
▸ ALOX12 P18054 1/20 0.56
▸ RECQL P46063 1/20 0.56
▸ PLAA Q9Y263 1/20 0.56
▸ L3MBTL1 Q9Y468 1/20 0.56
▸ USP2 O75604 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28669731 0.86 MAPK1 (0.60) SMN1; SMN2ALDH1A1MAPTHPGDMEN1
SCHEMBL28655968 0.86 KMT2A (0.58) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL28676731 0.83 HPGD (0.51) SMN1; SMN2LMNAALDH1A1HPGDMEN1
SCHEMBL21952045 0.83 LMNA (0.75) SMN1; SMN2LMNAALDH1A1MAPTHPGD
SCHEMBL24029051 0.82 MEN1 (0.53) SMN1; SMN2LMNAALDH1A1MAPTHPGD
SCHEMBL24029052 0.82 MEN1 (0.53) SMN1; SMN2LMNAALDH1A1MAPTHPGD
SCHEMBL24019625 0.82 MEN1 (0.53) SMN1; SMN2LMNAALDH1A1MAPTHPGD
SCHEMBL28673736 0.82 HPGD (0.53) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL28659325 0.82 KMT2A (0.51) ALDH1A1HPGDMEN1KMT2APOLB
SCHEMBL28654833 0.81 HPGD (0.54) SMN1; SMN2LMNAALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115768422-A Ubiquitin ligase inhibitors for the treatment of cancer 诺沃亚桑托斯教授基金会 2023-03-07 — — CN disclosed
CN-113677340-A Compounds that selectively and efficiently inhibit Hakai-mediated ubiquitination as anti-cancer agents 诺沃亚桑托斯教授基金会 2021-11-19 — — CN disclosed
Send feedback